Reduced healthcare costs for patients with screen-detected colorectal cancer: A Danish nationwide cohort study

IF 3.9 3区医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Public Health Pub Date : 2025-02-01 DOI:10.1016/j.puhe.2024.12.038

Jannie Dressler , Morten Rasmussen , Lars N. Jørgensen , Liza Sopina

{"title":"Reduced healthcare costs for patients with screen-detected colorectal cancer: A Danish nationwide cohort study","authors":"Jannie Dressler , Morten Rasmussen , Lars N. Jørgensen , Liza Sopina","doi":"10.1016/j.puhe.2024.12.038","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>This Danish nationwide retrospective register-based cohort study investigated healthcare costs for patients with screen-detected colorectal cancer (SD-CRC) compared to non-screen-detected CRC (NSD-CRC).</div></div><div><h3>Study design</h3><div>Nationwide cohort study.</div></div><div><h3>Methods</h3><div>Quarterly healthcare costs including costs of hospital care, out-of-hospital medication, and primary sector contacts were compared between the two groups from two years before diagnosis of CRC until two years after. A quasi-experimental difference-in-differences analysis was performed to estimate the differences per patient in total quarterly healthcare costs between the groups.</div></div><div><h3>Results</h3><div>A total of 13,852 patients were included, 4703 with SD-CRC, 7420 with NSD-CRC, and 1,729 with interval- or post-colonoscopy CRC (I-PC-CRC). The total quarterly healthcare costs per patient were significantly higher in the NSD-CRC group than in SD-CRC. This was consistent across the total period and in 6-month analyses, accruing additional €16,600 of costs for patients with NSD-CRC over two years after diagnosis. Total healthcare costs were significantly higher for patients with NSD-CRC as compared to patients with SD-CRC across all Union for International Cancer Control (UICC) stages, except for UICC stage I. Correspondingly, total costs associated with I-PC-CRC were significantly higher than for SD-CRC.</div></div><div><h3>Conclusions</h3><div>Apart from improving post-treatment outcomes, higher participation rates in the CRC screening programmes present an opportunity for reducing healthcare costs related to patients diagnosed with CRC.</div></div>","PeriodicalId":49651,"journal":{"name":"Public Health","volume":"239 ","pages":"Pages 62-69"},"PeriodicalIF":3.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0033350624005341","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

This Danish nationwide retrospective register-based cohort study investigated healthcare costs for patients with screen-detected colorectal cancer (SD-CRC) compared to non-screen-detected CRC (NSD-CRC).

Study design

Nationwide cohort study.

Methods

Quarterly healthcare costs including costs of hospital care, out-of-hospital medication, and primary sector contacts were compared between the two groups from two years before diagnosis of CRC until two years after. A quasi-experimental difference-in-differences analysis was performed to estimate the differences per patient in total quarterly healthcare costs between the groups.

Results

A total of 13,852 patients were included, 4703 with SD-CRC, 7420 with NSD-CRC, and 1,729 with interval- or post-colonoscopy CRC (I-PC-CRC). The total quarterly healthcare costs per patient were significantly higher in the NSD-CRC group than in SD-CRC. This was consistent across the total period and in 6-month analyses, accruing additional €16,600 of costs for patients with NSD-CRC over two years after diagnosis. Total healthcare costs were significantly higher for patients with NSD-CRC as compared to patients with SD-CRC across all Union for International Cancer Control (UICC) stages, except for UICC stage I. Correspondingly, total costs associated with I-PC-CRC were significantly higher than for SD-CRC.

Conclusions

Apart from improving post-treatment outcomes, higher participation rates in the CRC screening programmes present an opportunity for reducing healthcare costs related to patients diagnosed with CRC.

查看原文本刊更多论文

降低筛检结直肠癌患者的医疗费用：丹麦全国队列研究

目的：这项丹麦全国范围内基于登记的回顾性队列研究调查了筛查检测的结直肠癌（SD-CRC）患者与非筛查检测的结直肠癌（NSD-CRC）患者的医疗费用。研究设计：全国队列研究。方法：比较两组患者在结直肠癌诊断前两年至诊断后两年的季度医疗费用，包括住院护理费用、院外用药费用和初级部门接触费用。采用准实验的差异中差异分析来估计两组患者每季度总医疗保健费用的差异。结果：共纳入13852例患者，其中4703例为SD-CRC， 7420例为NSD-CRC， 1729例为结肠镜间期或结肠镜后CRC （I-PC-CRC）。每位患者每季度的总医疗费用在NSD-CRC组显著高于SD-CRC组。这在整个期间和6个月的分析中是一致的，在诊断后的两年内，非NSD-CRC患者的额外费用为16,600欧元。在国际癌症控制联盟（UICC）的所有分期中，除UICC期外，NSD-CRC患者的总医疗费用显著高于SD-CRC患者。相应地，I-PC-CRC患者的总医疗费用显著高于SD-CRC患者。结论：除了改善治疗后的结果外，CRC筛查项目参与率的提高为降低诊断为CRC的患者的医疗费用提供了机会。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Public Health 医学-公共卫生、环境卫生与职业卫生

CiteScore

7.60

自引率

0.00%

发文量

280

审稿时长

37 days

期刊介绍： Public Health is an international, multidisciplinary peer-reviewed journal. It publishes original papers, reviews and short reports on all aspects of the science, philosophy, and practice of public health.